Latest Press Releases

Health News Posted on Sunday, August 7, 2022

Premium Press Releases »

Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2

LONDON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time. Many scientists expect the virus that causes ...

Read More ...

Press Releases »

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

PALO ALTO, Calif. , Aug. 5, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, ...

Read More ...

Who's Next? Black Women's Health Imperative Urges Voters to Affirm Abortion Rights in Wake of Kansas Abortion-Referendum

ATLANTA , Aug. 5, 2022 /PRNewswire/ -- Earlier this week, Kansas voters rejected a proposed constitutional amendment that would have removed the right to abortion from the Kansas Constitution. For the sake of Black women's physical, ...

Read More ...

Indigenous Services Canada COVID-19 monthly update - August 2022

OTTAWA,ON, TRADITIONAL UNCEDED ALGONQUIN TERRITORY , Aug. 5, 2022 /CNW/ - COVID-19 case numbers are increasing with the current seventh wave, and it is impacting communities across the country. Indigenous Services Canada remains available to ...

Read More ...

WeTrade Group Announced a Strategic Partnership with Jiqing Bio Company, to Exclusively Sell Monkeypox Test Kits and Antigen Tests

BEIJING , Aug. 5, 2022 /PRNewswire/ -- On 5 th August, WeTrade Group Inc. ("Wetrade" or the "Company") (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent ...

Read More ...

United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms

New results demonstrate a newer class of anti-IgE antibody, UB-221, with superior neutralization, synthesis reduction, and durable relief in targeting allergic diseases   TAIPEI , Aug. 5, 2022 /PRNewswire/ -- United BioPharma (UBP) today ...

Read More ...

Center for Neurological Studies Announces National Symposium on Traumatic Brain Injury Diagnosis and Treatment

NOVI, Mich. , Aug. 4, 2022 /PRNewswire/ -- An estimated 2.5 million people suffer Traumatic Brain Injuries (TBI) annually in the United States with children, young adults and senior citizens being the most vulnerable. U. S. military ...

Read More ...

Dr. Christopher Walker Launches Hazel Walker Foundation to Help Women Access Free Health Care Services and Education

The nonprofit will support women in underserved communities by providing free contraceptives, reproductive health services, and resources ORLANDO, Fla. , Aug. 4 , 2022   /PRNewswire-PRWeb/ --  Hazel Walker Foundation (HWF), a nonprofit ...

Read More ...

American College of Lifestyle Medicine Offers Free Resources to Help People Eat Healthy and Affordable Meals During High Inflation

What people eat or don't eat is the biggest risk factor for morbidity and mortality. But rising prices are straining household finances and increasing the threat of food insecurity. The American College of Lifestyle Medicine (ACLM) is offering ...

Read More ...

Exam Master Launches Fee Assistance Program for PA-CAT Candidates

Effective immediately, Exam Master announces the release of a fee assistance program for the Physician Assistant College Admissions Test (PA-CAT). For economically eligible candidates, this program provides a significant discount off of the ...

Read More ...

John Brooks Recovery Center receives grant for Mobile Access to Medications for Substance Use Disorder

The initiative will enable JBRC to help increase the community's access to medications for substance use disorder. MAYS LANDING, N.J. , Aug. 4 , 2022   /PRNewswire-PRWeb/ --  John Brooks Recovery Center (JBRC) has received a $1 million ...

Read More ...

NACD's critically acclaimed app for treating apraxia has been re-released

The National Association for Child Development announces the re-release of their popular NACD Home Speech Therapist's Speech Therapy for Apraxia app, which has been a top medical app across the globe. The app is available on the Apple store. ...

Read More ...

Asymmetrex® Interviewed by Tech Company News About Plans to Introduce Online Rapid-Counting Calculators for Quantifying Therapeutic Tissue Stem Cells

In an August 2 feature in Tech Company News, stem cell biotechnology company Asymmetrex®'s CEO disclosed the company's plans to release its first generation of online calculators for rapid counting of therapeutic tissue stem cells. The company ...

Read More ...

F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

New Investment from Forbion and Sofinnova Partners MANCHESTER, England , Aug. 4, 2022 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat ...

Read More ...

UNION therapeutics announces enrollment of the first patient in ADESOS Phase 2b study of orismilast MR tablet in patients with atopic dermatitis

ADESOS is a Phase 2b dose-finding study of orismilast modified release (MR) tablet in moderate to severe atopic dermatitis (AD) with the purpose of identifying the appropriate dose-regimen for Phase 3 studies AD is the most common chronic ...

Read More ...

Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA

HANGZHOU, China and SHAOXING, China , Aug. 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the Investigational New Drug (IND) application of ASC10 , an oral inhibitor drug candidate targeting ...

Read More ...

Society for Immunotherapy of Cancer (SITC) Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Nonmelanoma Skin Cancer

The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication ...

Read More ...

Butterfly Medical Announces First BPH Clinical Study Procedures Performed in North America for its Next Generation Minimally Invasive Solution

First procedures were successfully performed under local anesthesia in an office setting by Steven Gange MD FACS, Summit Urology, Utah . YOKNEAM, Israel , Aug. 3, 2022 /PRNewswire-PRWeb/ --   Butterfly Medical , an Israeli medical ...

Read More ...

New Survey from Aeroflow Breastpumps Highlights Need for Increased Access to Breastfeeding Resources

More than half of pregnant and breastfeeding women nationwide believe there is not enough awareness surrounding the existence of lactation support services. ASHEVILLE, N.C. , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Aeroflow Breastpumps , a ...

Read More ...

Study Models Health and Economic Impacts of Increased Alcohol Consumption During COVID-19 Pandemic

RESEARCH TRIANGLE PARK, N.C. , Aug. 3, 2022 /PRNewswire/ -- A new study by experts at RTI International, a nonprofit research institute, estimates that a one-year increase in alcohol consumption during the COVID-19 pandemic will have a ...

Read More ...

EpicentRx Publishes Commentary in International Journal of Infectious Disease (IJID) on Need for a "Universal" Coronavirus Vaccine to be More Effective Against Novel Viral Variants

- Commentary points to need for a vaccine based on nucleocapsid vs. spike protein to make vaccine less vulnerable to mutation and provide stronger immunity to novel viral variants - Company's development of a nucleocapsid vaccine, a ...

Read More ...

Detecting Immunity to COVID just got a Whole Lot Easier

Enable Biosciences Reports Easier and Accurate SARS-CoV-2 Neutralizing Antibody Assay using Dried Blood Spot Samples SOUTH SAN FRANCISCO, Calif. , Aug. 3, 2022 /PRNewswire/ -- Scientists at Enable Biosciences report a novel method to ...

Read More ...

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia

CAMBRIDGE, Mass. , Aug. 3, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ...

Read More ...

Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China

HANGZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its innovative drug LNK01004, has been approved by ...

Read More ...

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

-   STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. -   STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea , Aug. 3, 2022 ...

Read More ...

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US

SUZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the ...

Read More ...

US-Based Biomedical Company Launches First Medical Probiotic Targeting Brain Health

Bened Life, Inc. releases its first product, Neuralli™ SAN FRANCISCO , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Bened Life is releasing the first gut-brain medical probiotic, Neuralli™, on Wednesday, August 3, 2022 . Made in the United States ...

Read More ...

Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19

KEY POINTS TADIOS was determined to be safe and well tolerated Serum levels of IL-1RA changed significantly, a biomarker that has a correlation with severity and mortality during COVID-19 infections Improvement in fatigue observed LA ...

Read More ...

TikoMed's ILB® activates the body's natural repair signals to restore glutamate homeostasis, amino acid metabolism and neurocognitive functions in a rat model of severe traumatic brain injury

VIKEN, Sweden , Aug. 3, 2022 /PRNewswire/ -- A new study with TikoMed's lead drug candidate, ILB®, addressing underlying causes of neurodegeneration in acute and chronic diseases, was published in the International Journal of Molecular ...

Read More ...

Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients

-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A, which is the same active metabolite of molnupiravir -- Ascletis has filed multiple patent applications for ASC10 and its ...

Read More ...

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

HAMBURG, Germany , Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. ...

Read More ...
More Press Releases

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store
CONSULT ONLINE WITH A DOCTOR